Cláudia M. Calvet - Concepedia

Author

Cláudia M. Calvet

Also Known As

Alvarez, Claudia, C CALVET, C. Calvet, C. M. CALVET, C.M Calvet, C.M. Calvet, CLAUDIA M. CALVET, CLAUDIA MAGALHÃES CALVET, Calvet, Claudia M., Claudia Alvarez

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz University of California San Diego Center for Discovery Universidade Federal Fluminense University of California, San Francisco

About

Cláudia M. Calvet is an author at Fundação Oswaldo Cruz specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	395
2	Biochemistry	6	6	148
3	Natural Sciences	5	5	138
4	Engineering	1	1	10
5	Biology	1	1	10

Cláudia M. Calvet

Publications

Citations

H-Index

Page 1

	Year	Citations
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51 Shamila S. Gunatilleke, Cláudia M. Calvet, Jonathan B. Johnston, PLoS neglected tropical diseases	2012	65
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease Bianca Olivieri, Judith Molina, Solange L. de Castro, International Journal of Antimicrobial Agents	2010	63
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM) Anjan Debnath, Cláudia M. Calvet, Gareth K. Jennings, PLoS neglected tropical diseases	2017	57
Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents Jun Yong Choi, Cláudia M. Calvet, Shamila S. Gunatilleke, Journal of Medicinal Chemistry	2013	51
SB-431542, a Transforming Growth Factor β Inhibitor, Impairs<i>Trypanosoma cruzi</i>Infection in Cardiomyocytes and Parasite Cycle Completion Mariana Caldas Waghabi, Michelle Kéramidas, Cláudia M. Calvet, Antimicrobial Agents and Chemotherapy Signaling PathwayAfrican TrypanosomiasisProtozoan Trypanosoma CruziReceptor Tyrosine KinasePathogenesis	2007	50
Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound Leonardo da Silva Lara, Caroline dos Santos Moreira, Cláudia M. Calvet, European Journal of Medicinal Chemistry Promising Hit CompoundAntiparasitic AgentMedicineParasitic ProtozoaAfrican Trypanosomiasis	2017	48
4-Aminopyridyl-Based CYP51 Inhibitors as Anti-<i>Trypanosoma cruzi</i>Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency Cláudia M. Calvet, Débora Vieira, Jun Yong Choi, Journal of Medicinal Chemistry	2014	47
Trypanosoma cruzi–cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo Cláudia M. Calvet, M. B. Meuser, Danielle da Silva Almeida, Experimental Parasitology CardiomyopathyFibrosisExtracellular Matrix ExpressionPathologyCell-matrix Interaction	2004	39
Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target Jonathan W Choy, Clifford Bryant, Cláudia M. Calvet, Beilstein Journal of Organic Chemistry	2013	39
Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease M. Monteiro, Guilherme C. Lechuga, Leonardo da Silva Lara, European Journal of Medicinal Chemistry Trypanocidal ActivityBiochemistryAntiparasitic AgentNatural SciencesMedicine	2019	35

Page 1